Ann: FDA Approves Early Feasibility Study for DurAVR THV System, page-44

Hi Mawson, that this has a few years to go may be the actual reality of where this company is at.
On that scenario there is unlikely to be a ‘early’ takeover and the prospect of several more placements.

That’s fine but what is not fine is the prospect of raising at languishing levels. That swathes of shares are issued at current levels becomes a shackle the company has not overcome. Buy at $20 or so, sell at higher levels then repeat over again.

$23 dollars by merit of two consolidations not thru sp appreciation.

I am for placements but at way higher levels, this though seems unlikely because it is not being allowed to, seemingly.

Imho.